SYNCOM FORMULATIONS (INDIA)
Back to Income Statement
|
SYNCOM FORMULATIONS (INDIA) Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2017 | Mar2016 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹25 Cr | ₹20 Cr | ₹20 Cr | ₹11 Cr | ₹10 Cr |
What is the latest Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹25 Cr |
Mar2023 | ₹20 Cr |
Mar2022 | ₹20 Cr |
Mar2017 | ₹11 Cr |
Mar2016 | ₹10 Cr |
How is Consolidated Net Profit of SYNCOM FORMULATIONS (INDIA) Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹25 Cr | 26.12 | |
Mar2023 | ₹20 Cr | 1.42 | |
Mar2022 | ₹20 Cr | 87.87 | |
Mar2017 | ₹11 Cr | 1.72 | |
Mar2016 | ₹10 Cr | - |
Compare Consolidated Net Profit of peers of SYNCOM FORMULATIONS (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SYNCOM FORMULATIONS (INDIA) | ₹1,948.6 Cr | 5.4% | -5.9% | 29.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SYNCOM FORMULATIONS (INDIA) | 5.4% |
-5.9% |
29.5% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses